Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1722711

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1722711

Autoinjector Market Report by Type (Disposable Autoinjectors, Reusable Autoinjectors), Application (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, and Others), End User (Home Care Settings, Hospitals and Clinics), and Region 2025-2033

PUBLISHED:
PAGES: 137 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2999
PDF & Excel (5 User License)
USD 3999
PDF & Excel (Corporate License)
USD 4999

Add to Cart

The global autoinjector market size reached USD 2.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.2 Billion by 2033, exhibiting a growth rate (CAGR) of 13.19% during 2025-2033. The increasing prevalence of chronic diseases, continuous advancements in biologics and biosimilars, the rising preference for home healthcare, numerous product innovations, and supportive reimbursement policies, are some of the factors driving the market.

Autoinjectors are self-injectable devices that help deliver drugs via the subcutaneous or intramuscular route. They offer several advantages, such as dosage accuracy and improved patient compliance, and help reduce needle phobia of patients, lower needlestick injuries resulting from a hidden needle, and increase the convenience and efficiency of healthcare professionals. They are widely used during emergency conditions, such as anaphylaxis, migraine, status epilepticus, psoriasis, diabetes, multiple sclerosis, and rheumatoid arthritis. As a result, autoinjectors find extensive applications in hospitals, clinics, and home care centers across the globe.

Autoinjector Market Trends:

At present, there is a rise in the prevalence of arthritis, asthma, cancer, chronic obstructive pulmonary disease (COPD) and Alzheimer's disease. This, along with the growing need for self-administrating medicines, represents one of the key factors driving the market. Moreover, governments of several countries are undertaking initiatives to promote the use of autoinjectors in schools. This, coupled with the increasing awareness among individuals about the benefits of autoinjectors, is propelling the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to develop simple, cost-effective, and new technology-based autoinjectors for treating rheumatoid arthritis and multiple sclerosis. Besides this, the rising adoption of targeted therapies to alter proteins within cancer cells and prevent the formation of new blood vessels in the tumor is offering lucrative growth opportunities to industry investors. Additionally, the burgeoning healthcare industry around the world is bolstering the growth of the market. Some of the other factors inducing growth are the increasing number of regulatory approvals, technological advancements, patent expiry of biologics and the availability of generic versions of autoinjectors.

Key Market Segmentation:

Breakup by Type:

  • Disposable Autoinjectors
  • Reusable Autoinjectors

Breakup by Application:

  • Rheumatoid Arthritis
  • Anaphylaxis
  • Multiple Sclerosis
  • Others

Breakup by End User:

  • Home Care Settings
  • Hospitals and Clinics

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Antares Pharma Inc., Becton Dickinson and Company, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Haselmeier GmbH (Sulzer Ltd.), Johnson & Johnson, Mylan N.V. (Viatris Inc.), Novartis AG, SHL Medical AG, Teva Pharmaceutical Industries Ltd. and Ypsomed Holding AG.

Key Questions Answered in This Report

  • 1.What was the size of the global autoinjector market in 2024?
  • 2.What is the expected growth rate of the global autoinjector market during 2025-2033?
  • 3.What are the key factors driving the global autoinjector market?
  • 4.What has been the impact of COVID-19 on the global autoinjector market?
  • 5.What is the breakup of the global autoinjector market based on the type?
  • 6.What is the breakup of the global autoinjector market based on the application?
  • 7.What is the breakup of the global autoinjector market based on the end user?
  • 8.What are the key regions in the global autoinjector market?
  • 9.Who are the key players/companies in the global autoinjector market?
Product Code: SR112025A5436

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Autoinjector Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Disposable Autoinjectors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reusable Autoinjectors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Rheumatoid Arthritis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Anaphylaxis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Multiple Sclerosis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Home Care Settings
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals and Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amgen Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Antares Pharma Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Becton Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eisai Co. Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Eli Lilly and Company
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Haselmeier GmbH (Sulzer Ltd.)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Johnson & Johnson
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Mylan N.V. (Viatris Inc.)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Novartis AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 SHL Medical AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Teva Pharmaceutical Industries Ltd.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Ypsomed Holding AG
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis
Product Code: SR112025A5436

List of Figures

  • Figure 1: Global: Autoinjector Market: Major Drivers and Challenges
  • Figure 2: Global: Autoinjector Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Autoinjector Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Autoinjector Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Autoinjector Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Autoinjector Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Autoinjector Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Autoinjector (Disposable Autoinjectors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Autoinjector (Disposable Autoinjectors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Autoinjector (Reusable Autoinjectors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Autoinjector (Reusable Autoinjectors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Autoinjector (Rheumatoid Arthritis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Autoinjector (Rheumatoid Arthritis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Autoinjector (Anaphylaxis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Autoinjector (Anaphylaxis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Autoinjector (Multiple Sclerosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Autoinjector (Multiple Sclerosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Autoinjector (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Autoinjector (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Autoinjector (Home Care Settings) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Autoinjector (Home Care Settings) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Autoinjector (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Autoinjector (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: North America: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: North America: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: United States: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: United States: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Canada: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Canada: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Asia-Pacific: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Asia-Pacific: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: China: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: China: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Japan: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Japan: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: India: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: India: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: South Korea: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: South Korea: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Australia: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Australia: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Indonesia: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Indonesia: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Others: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Others: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Europe: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Europe: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Germany: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Germany: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: France: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: France: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: United Kingdom: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: United Kingdom: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Italy: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Italy: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Spain: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Spain: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Russia: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Russia: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Latin America: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Latin America: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Brazil: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Brazil: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Mexico: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Mexico: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Middle East and Africa: Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Middle East and Africa: Autoinjector Market: Breakup by Country (in %), 2024
  • Figure 72: Middle East and Africa: Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Global: Autoinjector Industry: SWOT Analysis
  • Figure 74: Global: Autoinjector Industry: Value Chain Analysis
  • Figure 75: Global: Autoinjector Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Autoinjector Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Autoinjector Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Autoinjector Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Autoinjector Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Autoinjector Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Autoinjector Market: Competitive Structure
  • Table 7: Global: Autoinjector Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!